Inventor
LAMMINTAUSTA RISTO
FI17 patents
⚠️ This page may combine multiple inventors who share the name “LAMMINTAUSTA RISTO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORENDO PHARMA LTD
5 patentsUS10626140B2Apr 21, 2020
Prodrugs of 17β-HSD1-inhibitors
FORENDO PHARMA LTD0 citations47
US10377791B2Aug 13, 2019
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1
FORENDO PHARMA LTD0 citations38
US9850272B2Dec 26, 2017
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1
FORENDO PHARMA LTD0 citations38
US9663549B2May 30, 2017
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase
FORENDO PHARMA LTD0 citations38
US10413557B2Sep 17, 2019
Prodrugs of 17.BETA.-HSD1-inhibitors
FORENDO PHARMA LTD0 citations36
HORMOS MEDICAL OY LTD
3 patentsUS6875775B2Apr 5, 2005
Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HORMOS MEDICAL OY LTD31 citations90
US6576645B1Jun 10, 2003
Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HORMOS MEDICAL OY LTD35 citations90
US5972921AOct 26, 1999
Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
HORMOS MEDICAL OY LTD26 citations90
ORION YHTYMAE OY
3 patentsUS5304569AApr 19, 1994
Compositions and their use in lowering intraocular pressure
ORION YHTYMAE OY25 citations89
US5091402AFeb 25, 1992
Use of substituted imidazoles
ORION YHTYMAE OY24 citations86
US5464628ANov 7, 1995
Pharmaceutical compositions containing 4-substituted imidazoles to be administered transdermally
ORION YHTYMAE OY13 citations73